BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30451730)

  • 1. Accelerated Hypofractionated Radiation Therapy for Elderly Frail Bladder Cancer Patients Unfit for Surgery or Chemotherapy.
    Hammer L; Laufer M; Dotan Z; Leibowitz-Amit R; Berger R; Felder S; Weiss I; Lawrence YR; Symon Z
    Am J Clin Oncol; 2019 Feb; 42(2):179-183. PubMed ID: 30451730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole Versus Partial Bladder Radiation: Use of an Image-guided Hypofractionated IMRT Bladder-preservation Protocol.
    Kang JJ; Steinberg ML; Kupelian P; Alexander S; King CR
    Am J Clin Oncol; 2018 Feb; 41(2):107-114. PubMed ID: 26535994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is Ultra Hypofractionated Radiation Therapy a Safe and Effective Treatment for Invasive Bladder Cancer in the Elderly?: A Retrospective Single Institution Review.
    Symon N; Mattout J; Lewin R; Hammer L; Laufer M; Berger R; Leibowitz R; Dotan Z; Ben-Ayun M; Tsvang L; Weiss I; Symon Z
    Am J Clin Oncol; 2021 Jul; 44(7):369-373. PubMed ID: 33927135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypofractionated intensity modulated radiation therapy in combined modality treatment for bladder preservation in elderly patients with invasive bladder cancer.
    Turgeon GA; Souhami L; Cury FL; Faria SL; Duclos M; Sturgeon J; Kassouf W
    Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):326-31. PubMed ID: 24411604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promising results with image guided intensity modulated radiotherapy for muscle invasive bladder cancer.
    Whalley D; Caine H; McCloud P; Guo L; Kneebone A; Eade T
    Radiat Oncol; 2015 Sep; 10():205. PubMed ID: 26407726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Outcomes of Image Guided Adaptive Hypofractionated Weekly Radiation Therapy for Bladder Cancer in Patients Unsuitable for Radical Treatment.
    Hafeez S; McDonald F; Lalondrelle S; McNair H; Warren-Oseni K; Jones K; Harris V; Taylor H; Khoo V; Thomas K; Hansen V; Dearnaley D; Horwich A; Huddart R
    Int J Radiat Oncol Biol Phys; 2017 May; 98(1):115-122. PubMed ID: 28586948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder.
    Zietman AL; Grocela J; Zehr E; Kaufman DS; Young RH; Althausen AF; Heney NM; Shipley WU
    Urology; 2001 Sep; 58(3):380-5. PubMed ID: 11549485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curative radiation therapy for very elderly bladder cancer patients with localized disease.
    Bonet M; Bonfill T; Nuñez M; De Verdonces L; Mur E; Gallardo E; Fernandez-Morales L; Aguilar A; Prats J; Arenas M
    Clin Transl Oncol; 2018 Jul; 20(7):899-905. PubMed ID: 29159793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Outcomes With Dose-Escalated Adaptive Radiation Therapy for Urinary Bladder Cancer: A Prospective Study.
    Murthy V; Masodkar R; Kalyani N; Mahantshetty U; Bakshi G; Prakash G; Joshi A; Prabhash K; Ghonge S; Shrivastava S
    Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):60-66. PubMed ID: 26547385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of efficacy and toxicity in two different hypofractionated 3D-conformal external beam radiotherapy schedules in localised muscle invasive bladder cancer.
    Kouloulias V; Mosa E; Tolia M; Kantzou I; Koliarakis N; Platoni K; Georgakopoulos I; Siatelis A; Sarris G; Beli I; Chrisofos M; Kelekis N
    J BUON; 2013; 18(4):942-8. PubMed ID: 24344021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment results of radiation therapy for muscle-invasive bladder cancer.
    Langsenlehner T; Döller C; Quehenberger F; Stranzl-Lawatsch H; Langsenlehner U; Pummer K; Kapp KS
    Strahlenther Onkol; 2010 Apr; 186(4):203-9. PubMed ID: 20354664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of the technique and comorbidities in hypofractionated radiotherapy for prostate cancer.
    Correa R; Navarro I; Lobato M; Otero A; Jerez I; Rico JM; Zapata I; Lupiañez Y; Medina JA; Olmos D; Gómez-Millán J
    Clin Transl Oncol; 2020 Mar; 22(3):311-318. PubMed ID: 31721011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Efficacy of Hypofractionated Radiotherapy With Capecitabine in Elderly Patients With Urothelial Carcinoma.
    Leng J; Akthar AS; Szmulewitz RZ; O'Donnell PH; Sweis RF; Pitroda SP; Smith N; Steinberg GD; Liauw SL
    Clin Genitourin Cancer; 2019 Feb; 17(1):e12-e18. PubMed ID: 30392939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Could Concurrent Capecitabine with Hypofractionated Radiotherapy in Elderly Patients with Muscle-Invasive Bladder Cancer be an Option?
    Youssief AA; Gamal DA; El-Naggar MS; Zarzor MA; A R; Ahmed S
    Asian Pac J Cancer Prev; 2022 May; 23(5):1733-1740. PubMed ID: 35633559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of morbidity following conformal versus intensity-modulated radiotherapy for urinary bladder cancer.
    Søndergaard J; Holmberg M; Jakobsen AR; Agerbæk M; Muren LP; Høyer M
    Acta Oncol; 2014 Oct; 53(10):1321-8. PubMed ID: 24980045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical results of conformal versus intensity-modulated radiotherapy using a focal simultaneous boost for muscle-invasive bladder cancer in elderly or medically unfit patients.
    Lutkenhaus LJ; van Os RM; Bel A; Hulshof MC
    Radiat Oncol; 2016 Mar; 11():45. PubMed ID: 26993980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrent cisplatin, 5-fluorouracil, leucovorin, and radiotherapy for invasive bladder cancer.
    Chen WC; Liaw CC; Chuang CK; Chen MF; Chen CS; Lin PY; Chang PL; Chu SH; Wu CT; Hong JH
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):726-33. PubMed ID: 12788178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy for muscle-invasive carcinoma of the bladder: results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapy.
    Cowan RA; McBain CA; Ryder WD; Wylie JP; Logue JP; Turner SL; Van der Voet J; Collins CD; Khoo VS; Read GR
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):197-207. PubMed ID: 15093917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent platinum and docetaxel chemotherapy and external radical radiotherapy in patients with invasive transitional cell bladder carcinoma. A preliminary report of tolerance and local control.
    Varveris H; Delakas D; Anezinis P; Haldeopoulos D; Mazonakis M; Damilakis J; Metaxaris G; Chondros N; Mavromanolakis E; Daskalopoulos G; Dimitrakopoulos A; Kranidis A
    Anticancer Res; 1997; 17(6D):4771-80. PubMed ID: 9494605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal management of recurrent and metastatic upper tract urothelial carcinoma: Implications of intensity modulated radiation therapy.
    Kim MS; Koom WS; Cho JH; Kim SY; Lee IJ
    Radiat Oncol; 2022 Mar; 17(1):51. PubMed ID: 35264197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.